Hannah Moore, a courageous survivor from Guildford, Surrey, faced the daunting challenge of leukaemia when she was diagnosed with acute lymphoblastic leukaemia at the tender age of just two-and-a-half years.
After enduring several rounds of intense chemotherapy, along with regular blood tests and lumbar punctures, Hannah eventually triumphed over the illness and went into remission. However, her doctors cautioned her about significant side-effects from the treatment. They explained that she could face infertility as an adult, a heartbreaking prospect she had to grapple with.
At 28, Hannah, now a devoted mother of three, passionately advocates for research initiatives aimed at developing gentler cancer treatments suitable for children and other vulnerable patients. The groundbreaking work supported by Leukaemia UK resonates deeply with her personal experience and her commitment to ensuring that others may have a less traumatic journey.
Having received the news at the age of 18 during her final appointment on the children’s ward, Hannah learned about the potential long-term effects of her illness, including heart complications that would require constant monitoring and the grim likelihood of facing early menopause.
At 21, when Hannah met her future husband, Carl, they began their journey towards parenthood. “I was so relieved when I did fall pregnant,” she shared, beautifully reflecting on her fears of infertility. “I would have been heartbroken if I hadn’t been able to have children. They were all completely normal pregnancies and babies, although the consultants did keep a close eye on me throughout.”
“It was such an amazing feeling when each baby was here safely,” she added, emphasizing her desire to be the best mother possible. “I am incredibly proud to support the charity Leukaemia UK. The research taking place is incredible and is going to be lifesaving.”
Each year, Leukaemia UK awards four £150,000 grants to early career researchers, supporting ambitious visions for the future of cancer treatment. One such recipient, Dr. Yang Li from University College London, is utilizing the funding to investigate gentler, more effective alternative therapies specifically for vulnerable patients, including children and those facing relapse.
It is hoped that Dr. Li’s pioneering research will significantly diminish the harsh side effects associated with traditional treatments, potentially transforming the landscape of childhood cancer care.
What inspired you to become an advocate for childhood cancer research after your own experience with leukemia?
**Interview with Hannah Moore: Survivor and Advocate for Childhood Cancer Research**
**Editor**: Hannah, thank you for joining us today and sharing your inspiring journey. Could you start by telling us a bit about your experience with leukemia at such a young age?
**Hannah Moore**: Thank you for having me! My journey with acute lymphoblastic leukemia began when I was just two-and-a-half. It was incredibly challenging—so many hospital visits, painful procedures, and an overwhelming amount of chemotherapy. But I was lucky; I went into remission after those difficult years.
**Editor**: That’s truly a remarkable journey, especially at such a young age. You mentioned the side effects from treatment, particularly regarding infertility. How did that knowledge affect you growing up?
**Hannah Moore**: It was tough to handle. Growing up, I often thought about what my future would look like, especially when it came to starting a family. Knowing that I could face infertility was daunting, and at times, it felt unfair. But I focused on living my life to the fullest and ensuring that I could still have a meaningful family experience.
**Editor**: Now at 28 and a devoted mother of three, you’ve become an advocate for research initiatives in cancer treatment. What sparked this passion?
**Hannah Moore**: My own experiences have fueled my desire to see improvements in treatments for children. Many young patients, like I was, endure harsh therapies that can lead to long-term health issues. I work with organizations like Leukaemia UK to support research that aims to develop gentler, more effective treatments for vulnerable patients. It’s all about improving survival rates while minimizing long-term effects.
**Editor**: It’s so heartwarming to hear your commitment to this cause. In your opinion, what do you believe is the most crucial step in advancing treatment for childhood leukemia?
**Hannah Moore**: Research is vital. We need more funding and support for studies focused on pediatric treatment options. Additionally, it’s essential to raise awareness about these issues so that more people understand the challenges faced by childhood cancer survivors. I hope that sharing my story helps inspire conversations around that need.
**Editor**: Your advocacy work is invaluable, and we thank you for your courage and dedication. As a survivor, what message do you want to share with others facing similar challenges?
**Hannah Moore**: To anyone currently battling leukemia or any form of cancer, I want you to know that you’re not alone. It’s okay to feel a wide range of emotions, and it’s important to reach out for support. Focus on your goals, and remember that there are people and organizations out there fighting for better treatments and outcomes for you.
**Editor**: Thank you, Hannah. Your story is truly inspiring and a reminder of the resilience of the human spirit. We appreciate you taking the time to speak with us today.
**Hannah Moore**: Thank you for having me! It’s a privilege to share my journey and advocate for change.
